I Wasn’t ‘Just a Patient’ to My Oncology Nurse
My oncology nurse has been making connections with her patients for more than 20 years. I’m forever grateful I was lucky to be her patient.
CURE Media Group Announces Winners of 2022 Calendar Contest
Twelve winners were selected from 113 submissions to have their artwork featured in its annual calendar contest.
MPN Heroes® Recognition Program 2021
Watch the entire MPN Heroes® Recognition Program here!
Educated Patient® Webinar: Testing and Treatment for Non-Small Cell Lung Cancer
View the full CURE® Educated Patient® Webinar: Testing and Treatment for Non-Small Cell Lung Cancer on demand.
Educated Patient® Webinar: Meet the 2021 Lung Cancer Heroes®
View the full CURE® Educated Patient® Webinar: Meet the 2021 Lung Cancer Heroes® on demand.
Educated Patient® Breast Cancer Summit Outside of Therapy Session: November 13, 2021
View the full CURE Educated Patient Breast Cancer Summit Outside of Therapy Session on demand.
Educated Patient® Breast Cancer Summit Novel Therapies Session: November 13, 2021
View the full CURE Educated Patient Breast Cancer Summit Novel Therapies Session on demand.
Educated Patient® Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session: November 13, 2021
View the full CURE Educated Patient Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session on demand.
Educated Patient® Webinar: Stomach Cancer 101 Series: Part III – Survivorship and Mental Health
View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part III – Survivorship and Mental Health
CURE Media Group Welcomes Nine New Partners to Strategic Alliance Partnership Program
The SAP program is a collaborative platform to showcase cutting-edge initiatives, research, and thought leadership.
Adopting Precision Medicine in NSCLC
Take-home messages from a discussion on the use of biomarker testing, and newer, novel-based strategies to treat patients with non-small cell lung cancer.
Rechallenging Therapy in NSCLC
Preferences for rechallenging patients with non-small cell lung cancer with immunotherapy based on previous experiences in terms of treatment-related side effects.
NSCLC: Preparing Patients for Treatment-Related Side Effects
Strategies that can help various health care professionals best mitigate or manage side effects associated with newer treatments in non-small cell lung cancer, such as immunotherapy.
Shared Decision-Making in NSCLC
The significance of shared decision-making between patients and lung oncologists when considering a novel-based therapy as treatment for non-small cell lung cancer.
Immunotherapy for Patients With NSCLC
Considerations for treating patients with non-small cell lung cancer with single-agent immunotherapy vs chemoimmunotherapy.
Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options
View the full CURE® Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options on demand.
Lung Cancer Heroes Awards 2021
Watch the entire Lung Cancer Heroes® presentation here!
The Importance of Shared Decision-Making in Receiving Molecular Testing for NSCLC
Stephen Liu, MD, and Danielle Hicks clarify the importance of involving patients and caregivers in discussions about non-small cell lung cancer molecular testing.
Targeted Therapies in Non-Small Cell Lung Cancer
Thought leaders give an overview on KRAS-mutated non-small cell lung cancer and the treatment options available.
Educated Patient® Kidney Cancer Summit: October 24, 2021
View the full CURE Educated Patient Kidney Cancer Summit on demand.
Repeat Biopsies as NSCLC Progresses
Preferences for repeat biopsies upon progression in non-small cell lung cancer following frontline therapy with a targeted treatment approach.
PD-L1 Testing in NSCLC
The pros and cons of conducting PD-L1 testing in patients with non-small cell lung cancer.
Biomarker Testing and the Impact on Treatment Selection for NSCLC
Stephen Liu, MD, and Danielle Hicks illustrate how molecular testing impacts targeted therapy selection in non-small cell lung cancer.
Discussing Biomarker Testing in NSCLC With Patients
Key opinion leaders explain how to discuss biomarker testing with non-small cell lung cancer patients, as well as the common questions they field.
Individualized Treatment Decisions for Patients With NSCLC
The rationale for waiting on results of molecular testing prior to initiating treatment for patients with non-small cell lung cancer.
Tissue and Liquid Biopsies in NSCLC
The difference between tissue and liquid biopsies used in non-small cell lung cancer, and what patients should know about their results and treatment decision-making.
Biomarker Testing in Non-Small Cell Lung Cancer
Stephen Liu, MD, and Danielle Hicks describe the purpose and the importance of biomarker testing in non-small cell lung cancer.
NSCLC: Future Directions in Care and Take-Home Messages
Shared insight on novel treatments for non-small cell lung cancer and how patients should advocate for themselves and seek best available care.
Non-Small Cell Lung Cancer: Taking a Break From Treatment
Allison Collins shares her experience undergoing a break from therapy after she responded well to treatment for non-small cell lung cancer.
Counseling Patients With NSCLC About Molecular Testing
What patients need to know about molecular testing and treatment decisions in non-small cell lung cancer.